{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:34:04Z","timestamp":1777923244627,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jpha.2017.03.010","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T04:01:10Z","timestamp":1493265670000},"page":"297-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Degradation rates and products of fluticasone propionate in alkaline solutions"],"prefix":"10.1016","volume":"7","author":[{"given":"Tadakazu","family":"Tokumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanami","family":"Mori-Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2017.03.010_bib1","doi-asserted-by":"crossref","unstructured":"British Thoracic Society, Guidelines on the management of asthma, Thorax. 48 (1993) S1\u2013S24.","DOI":"10.1136\/thx.48.2_Suppl.S1"},{"issue":"Supplement 1","key":"10.1016\/j.jpha.2017.03.010_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(08)80004-2","article-title":"The human pharmacology of fluticasone propionate","volume":"84","author":"Harding","year":"1990","journal-title":"Respin. Med."},{"issue":"Supplement 1","key":"10.1016\/j.jpha.2017.03.010_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0954-6111(05)80034-4","article-title":"Pharmacology of fluticasone propionate","volume":"88","author":"Shaw","year":"1994","journal-title":"Respir. Med."},{"key":"10.1016\/j.jpha.2017.03.010_bib4","first-page":"535","article-title":"The clinical pharmacology of fluticasone propionate","volume":"9","author":"Meibohm","year":"1998","journal-title":"Rev. Contemp. Pharmacother."},{"key":"10.1016\/j.jpha.2017.03.010_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10847-012-0159-z","article-title":"Colon targeting of fluticasone propionate inclusion complex: a novel approach in inflammatory bowel disease","volume":"75","author":"Thakral","year":"2013","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.jpha.2017.03.010_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00054725-199506000-00006","article-title":"New steroids for inflammatory bowel disease","volume":"1","author":"Loefberg","year":"1995","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jpha.2017.03.010_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/thx.54.7.614","article-title":"Evaluation of buccal component of systemic absorption with inhaled fluticasone propionate","volume":"54","author":"Dempsey","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.jpha.2017.03.010_bib8","first-page":"1134","article-title":"The influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients","volume":"57","author":"Miyagawa","year":"2008","journal-title":"Jpn. J. Allergol."},{"key":"10.1016\/j.jpha.2017.03.010_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1208\/s12248-015-9768-y","article-title":"A systematic analysis of the sensitivity of plasma pharmacokinetics to detect difference in the pulmonary performance of inhaled fluticasone propionate products using a model-based simulation approach","volume":"17","author":"Weber","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jpha.2017.03.010_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","article-title":"Role of cytokines in the pathogenesis of inflammatory bowel disease","volume":"51","author":"Papadakis","year":"2000","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.jpha.2017.03.010_bib11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jpha.2017.03.010_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2169\/naika.101.643","article-title":"Recent advances in the treatment of inflammatory bowel disease","volume":"101","author":"Watanabe","year":"2012","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"10.1016\/j.jpha.2017.03.010_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1756283X12473675","article-title":"Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity","volume":"6","author":"Prantera","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.jpha.2017.03.010_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2165\/00002018-199106030-00005","article-title":"Risk-benefit assessment of drugs used in the treatment of inflammatory bowel diseases","volume":"6","author":"Hanauer","year":"1991","journal-title":"Drug Saf."},{"key":"10.1016\/j.jpha.2017.03.010_bib15","first-page":"19","article-title":"Solubility of fluticasone propionate in aqueous solutions measured by a method avoiding its adsorption to experimental tools","volume":"4","author":"Tokumura","year":"2014","journal-title":"Int. Res. J. Pharm. Appl. Sci."},{"key":"10.1016\/j.jpha.2017.03.010_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jddst.2015.02.002","article-title":"An inclusion complex of fluticasone propionate with \u03b3-cyclodextrin in aqueous solution and in a solid state","volume":"26","author":"Tokumura","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jpha.2017.03.010_bib17","first-page":"1","article-title":"Degradation rate of fluticasone propionate in an alkaline solution of 0.1 N NaOH:methanol=1:1","volume":"4","author":"Tokumura","year":"2014","journal-title":"Int. Res. J. Pharm. Appl. Sci."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177917300230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177917300230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:29:14Z","timestamp":1761859754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177917300230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2095177917300230"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2017.03.010","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Degradation rates and products of fluticasone propionate in alkaline solutions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2017.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}